Horizon Discovery Group plc appoints Mr Grahame Cook as a Non-Executive Director
Advertisement
Horizon Discovery Group plc announced the appointment of Mr Grahame Cook as a Non-Executive Director of the Board with immediate effect. Grahame has also been appointed to the Audit Committee, within which he will assume the role of Chairman.
Grahame Cook is an experienced FTSE and AIM non-executive, with extensive experience as an audit committee chairman. With a background in banking, where he has specialised in the life sciences, pharma and biotech sectors, Grahame has over 20 years’ experience of M&A, equity capital markets and investor relations.
Grahame started his career at Arthur Andersen, where he qualified as a chartered accountant and worked within audit and corporate investigations. Subsequent positions include UBS, where he was a member of the global investment banking management committee and global head of equity advisory, and WestLB Panmure, where he was joint Chief Executive Officer. Grahame currently sits on a number of boards, chairing four, including Sinclair Pharma plc and Morphogenesis Inc.
Grahame is a graduate of the University of Oxford and remains a member of the ICAEW.
Most read news
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Bacterial glitter: New findings open up possibilities for sustainable color technologies - Predictions with artificial intelligence

Better Understanding Membranes - A new class of membranes promises highly interesting applications in material separation, whether in biotechnology or water purification
New study suggests sickle cell disease may affect brain function in adults
Armed_Forces_Radiobiology_Research_Institute

X-ray laser reveals structure of blood pressure regulator - Promising step towards new and better medication

Nanoparticles for 3-D printing in water open door to advanced biomedical materials
CuraGen and TopoTarget Initiate NCI-sponsored Phase I Clinical Trial of PXD101 and Azacitidine
Köhler_disease
Consortium lead by Prophylix Pharma AS receives up to €6 M in EU-funding - The EU grant is for development of a prophylactic treatment to prevent severe bleeding and death in newborns caused by Fetal/Neonatal Alloimmune Trombocytopenia
Progress in pursuit of sickle cell cure
Analytik Jena Opens Swiss Branch Office at the Endress+Hauser Headquarters
